Skip to main content
Retour
Watch Compare

Bionano Genomics, Inc.

Qualité des données : 100%
BNGO
Nasdaq Manufacturing Measuring & Analyzing Instruments
1,15 €
▼ 0,04 € (-2,97%)
Cap. Boursière: 12,70 M
Prix
1,15 €
Cap. Boursière
12,70 M
Fourchette du Jour
1,14 € — 1,19 €
Fourchette 52 Semaines
1,06 € — 5,50 €
Volume
100 614
Ouverture 1,19 €
Moyenne 50J / 200J
1,19 €
4,12% below
Moyenne 50J / 200J
2,11 €
45,77% below

Quick Summary

Points Clés

Revenue grew 12,21% annually over 5 years — strong growth
Negative free cash flow of -16,35 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 19,58%

Croissance

Revenue Growth (5Y)
12,21%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)-7,37%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-55,47%
En dessous de la moyenne du secteur (-53,47%)
ROIC-48,81%
Net Margin-92,59%
Op. Margin-116,95%

Sécurité

Debt / Equity
N/A
Current Ratio2,12
Interest CoverageN/A

Valorisation

PE (TTM)
-0,48
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio0,26
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B 0,3 1,6
ROE % -55,5 -53,5
Net Margin % -92,6 -41,5
Rev Growth 5Y % 12,2 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -7,37% Revenue Growth (3Y) -11,15%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12,21% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 28,51 M Net Income (TTM) -26,40 M
ROE -55,47% ROA -34,04%
Gross Margin N/A Operating Margin -116,95%
Net Margin -92,59% Free Cash Flow (TTM) -16,35 M
ROIC -48,81% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,12
Interest Coverage N/A Asset Turnover 0,37
Working Capital 25,82 M Tangible Book Value 44,11 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,48 Forward P/E N/A
P/B Ratio 0,26 P/S Ratio 0,45
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -128,70%
Market Cap 12,70 M Enterprise Value 9,64 M
Per Share
EPS (Diluted TTM) -4,85 Revenue / Share 2,57
FCF / Share -1,47 OCF / Share -1,47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 61,92%
SBC-Adj. FCF -22,16 M Growth Momentum -19,58

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 28,51 M 30,78 M 36,12 M 27,80 M 17,98 M
Net Income -26,40 M -112,02 M -232,49 M -132,60 M -72,44 M
EPS (Diluted) -4,85 -88,13 -6,81 -0,46 —
Gross Profit — — — — —
Operating Income -33,34 M -103,98 M -215,25 M -131,70 M -77,10 M
EBITDA — — — — —
R&D Expenses 11,37 M 24,80 M 54,03 M 49,05 M 22,49 M
SG&A Expenses 35,15 M 51,86 M 93,50 M 88,60 M 58,49 M
D&A 9,53 M 14,02 M 13,71 M 9,62 M 3,35 M
Interest Expense — — 5,12 M 298 000,0 927 000,0
Income Tax 67 000,0 33 000,0 62 000,0 1,88 M -5,72 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 73,58 M 76,67 M 214,40 M 307,50 M 377,10 M
Total Liabilities 29,16 M 41,30 M 118,25 M 58,10 M 39,98 M
Shareholders' Equity 44,42 M 35,38 M 96,16 M 249,40 M 337,12 M
Total Debt — — — — 16,33 M
Cash & Equivalents 2,99 M 9,17 M 17,95 M 5,09 M 24,57 M
Current Assets 45,39 M 39,49 M 140,12 M 157,30 M 272,41 M
Current Liabilities 22,94 M 37,34 M 100,03 M 35,88 M 21,84 M